ERIS: The R&D Tax Relief Loss-Making Biotechs Should Know About
*Guest blog by LimestoneGrey. If you would like to submit a guest blog please email [email protected].
Two loss-making biotechs each spend £100,000 on qualifying R&D in the same year. One receives £16,200 in cash. The other receives £26,970. Nothing they did in the lab was different. The difference? One ratio.
What Enhanced R&D Intensive Support is